Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Peptris Technologies out-licenses AI-discovered drug candidate to Revio Therapeutics
Under the agreement, Revio Therapeutics will hold commercialisation rights to PEPR124 (RT001) in all markets except in BRICS…
AstraZeneca to acquire EsoBiotec to advance cell therapy ambition
EsoBiotec will become a wholly owned subsidiary of AstraZeneca, with operations in Belgium
Zydus receives final USFDA approval for Eluxadoline Tablets, 75 mg and 100 mg
Eluxadoline is a mu-opioid receptor agonist, indicated in adults for the treatment of irritable bowel syndrome with diarrhoea…
AI-driven drug discovery, precision medicine, and sustainable manufacturing can redefine the pharma…
Ramandeep Singh, Vice President, Life Sciences and Healthcare, India, Clarivate, discusses the latest innovative R&D,…
IA-2A positivity could help develop effective intervention strategies in type 1 diabetes…
IA-2A identified as a key biomarker for type 1 diabetes risk stratification and early intervention strategies
H.E.L Group and ICT Mumbai sign research agreement to enhance process safety in chemical synthesis
H.E.L Group to provide simular reaction Calorimeter to ICT Mumbai for process safety research and education
Tenthpin Management Consultants launches AI labs in Hyderabad to drive life sciences Innovation
Global consulting firm Tenthpin establishes AI-focused Centre of Excellence in Hyderabad to accelerate AI adoption in Life…
IPA questions FAERS data interpretation in the Ohio State University study
The Indian Pharmaceutical Alliance (IPA) states that a higher rate of serious adverse events (SAEs) for drugs manufactured in…
Zydus Lifesciences receives USFDA approval for Methenamine Hippurate tablets
Approval allows Zydus to manufacture and market 1-gram Methenamine Hippurate tablets in the United States
Davaindia expands in Kerala to improve access to affordable generic medicines
With over 50 stores in Kerala, Davaindia aims to expand further into Tier 2 and rural areas while promoting awareness of generic…